PT - JOURNAL ARTICLE AU - H. M. Maling AU - B. Highman AU - S. Spector TI - NEUROLOGIC, NEUROPATHOLOGIC, AND NEUROCHEMICAL EFFECTS OF PROLONGED ADMINISTRATION OF PHENYLISOPROPYLHYDRAZINE (JB 516), PHENYLISOBUTYLHYDRAZINE (JB 835), AND OTHER MONOAMINE OXIDASE INHIBITORS DP - 1962 Nov 01 TA - Journal of Pharmacology and Experimental Therapeutics PG - 285--285 VI - 138 IP - 2 4099 - http://jpet.aspetjournals.org/content/138/2/285.3.short 4100 - http://jpet.aspetjournals.org/content/138/2/285.3.full SO - J Pharmacol Exp Ther1962 Nov 01; 138 AB - In the paper entitled "Neurologic, Neuropathologic, and Neurochemical Effects of Prolonged Administration of Phenylisopropylhydrazine (JB 516), Phenylisobutylhydrazine (JB 835), and Other Monoamine Oxidase Inhibitors" by H. M. Maling, B. Highman and S. Spector (Vol. 137, No. 3, September 1962), there is an error on page 338, table 4, last column, line 5. The 3.2 mg/kg oral daily dose of JB 516 showed an incidence of lesions in the pyriform lobe of 0/4 instead of 2/4 as printed.